These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 32438018)

  • 1. QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review.
    Jankelson L; Karam G; Becker ML; Chinitz LA; Tsai MC
    Heart Rhythm; 2020 Sep; 17(9):1472-1479. PubMed ID: 32438018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection.
    Saleh M; Gabriels J; Chang D; Soo Kim B; Mansoor A; Mahmood E; Makker P; Ismail H; Goldner B; Willner J; Beldner S; Mitra R; John R; Chinitz J; Skipitaris N; Mountantonakis S; Epstein LM
    Circ Arrhythm Electrophysiol; 2020 Jun; 13(6):e008662. PubMed ID: 32347743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin.
    Chorin E; Wadhwani L; Magnani S; Dai M; Shulman E; Nadeau-Routhier C; Knotts R; Bar-Cohen R; Kogan E; Barbhaiya C; Aizer A; Holmes D; Bernstein S; Spinelli M; Park DS; Stefano C; Chinitz LA; Jankelson L
    Heart Rhythm; 2020 Sep; 17(9):1425-1433. PubMed ID: 32407884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QT Interval Control to Prevent Torsades de Pointes during Use of Hydroxychloroquine and/or Azithromycin in Patients with COVID-19.
    Wu TC; Sacilotto L; Darrieux FCDC; Pisani CF; Melo SL; Hachul DT; Scanavacca M
    Arq Bras Cardiol; 2020 Jun; 114(6):1061-1066. PubMed ID: 32638906
    [No Abstract]   [Full Text] [Related]  

  • 5. Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring.
    Ramireddy A; Chugh H; Reinier K; Ebinger J; Park E; Thompson M; Cingolani E; Cheng S; Marban E; Albert CM; Chugh SS
    J Am Heart Assoc; 2020 Jun; 9(12):e017144. PubMed ID: 32463348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chloroquine-induced torsades de pointes in a patient with coronavirus disease 2019.
    Szekely Y; Lichter Y; Shrkihe BA; Bruck H; Oster HS; Viskin S
    Heart Rhythm; 2020 Sep; 17(9):1452-1455. PubMed ID: 32380291
    [No Abstract]   [Full Text] [Related]  

  • 7. Response to the editorial "COVID-19 in patients with cardiovascular diseases": Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes.
    Funck-Brentano C; Salem JE; Nguyen LS; Drici MD; Roden DM
    Arch Cardiovasc Dis; 2020 May; 113(5):367-368. PubMed ID: 32331979
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19).
    Mercuro NJ; Yen CF; Shim DJ; Maher TR; McCoy CM; Zimetbaum PJ; Gold HS
    JAMA Cardiol; 2020 Sep; 5(9):1036-1041. PubMed ID: 32936252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic (hydroxy)chloroquine in COVID-19: Potential relevance for cardiac arrhythmia risk.
    Offerhaus JA; Wilde AAM; Remme CA
    Heart Rhythm; 2020 Sep; 17(9):1480-1486. PubMed ID: 32622993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chloroquine or Hydroxychloroquine for Management of Coronavirus Disease 2019: Friend or Foe?
    Schluenz LA; Ramos-Otero GP; Nawarskas JJ
    Cardiol Rev; 2020; 28(5):266-271. PubMed ID: 32769401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine.
    Sarayani A; Cicali B; Henriksen CH; Brown JD
    Res Social Adm Pharm; 2021 Feb; 17(2):483-486. PubMed ID: 32327397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged QT Interval in a Patient With Coronavirus Disease-2019: Beyond Hydroxychloroquine and Azithromycin.
    Anupama BK; Adhikari S; Chaudhuri D
    J Investig Med High Impact Case Rep; 2020; 8():2324709620948407. PubMed ID: 32762368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol.
    Naksuk N; Lazar S; Peeraphatdit TB
    Eur Heart J Acute Cardiovasc Care; 2020 Apr; 9(3):215-221. PubMed ID: 32372695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saudi Heart Rhythm Society Task Force on Management of Potential Arrhythmogenicity Associated with Pharmacotherapy for COVID-19.
    AlShoaibi NA; Maghrabi K; Alanazi H; Harbi MA; Alghamdi S
    Ann Saudi Med; 2020; 40(5):365-372. PubMed ID: 32954790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QT Interval Prolongation Under Hydroxychloroquine/Azithromycin Association for Inpatients With SARS-CoV-2 Lower Respiratory Tract Infection.
    Bun SS; Taghji P; Courjon J; Squara F; Scarlatti D; Theodore G; Baudouy D; Sartre B; Labbaoui M; Dellamonica J; Doyen D; Marquette CH; Levraut J; Esnault V; Bun SS; Ferrari E
    Clin Pharmacol Ther; 2020 Nov; 108(5):1090-1097. PubMed ID: 32588427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hazard of acquired long QT syndrome during coronavirus pandemic. Focus on hydroxychloroquine].
    Tomcsányi J; Tomcsányi K
    Orv Hetil; 2020 Apr; 161(17):689-691. PubMed ID: 32324363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QTc prolongation in COVID-19 patients treated with hydroxychloroquine, chloroquine, azithromycin, or lopinavir/ritonavir: A systematic review and meta-analysis.
    Diaz-Arocutipa C; Brañez-Condorena A; Hernandez AV
    Pharmacoepidemiol Drug Saf; 2021 Jun; 30(6):694-706. PubMed ID: 33772933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced electrocardiographic monitoring of patients with Coronavirus Disease 2019.
    Jain S; Workman V; Ganeshan R; Obasare ER; Burr A; DeBiasi RM; Freeman JV; Akar J; Lampert R; Rosenfeld LE
    Heart Rhythm; 2020 Sep; 17(9):1417-1422. PubMed ID: 32387247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review.
    Hernandez AV; Roman YM; Pasupuleti V; Barboza JJ; White CM
    Ann Intern Med; 2020 Aug; 173(4):287-296. PubMed ID: 32459529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin.
    Chorin E; Dai M; Shulman E; Wadhwani L; Bar-Cohen R; Barbhaiya C; Aizer A; Holmes D; Bernstein S; Spinelli M; Park DS; Chinitz LA; Jankelson L
    Nat Med; 2020 Jun; 26(6):808-809. PubMed ID: 32488217
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 32.